Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study

Cancer

Volumn 121, Issue 20, 2015, Pages 3684-3691

  Cheng, Ting Yuan David ^a,b   Makar, Karen W ^a   Neuhouser, Marian L ^a   Miller, Joshua W ^c,d   Song, Xiaoling ^a   Brown, Elissa C ^a   Beresford, Shirley A A ^a   Zheng, Yingye ^a   Poole, Elizabeth M ^e   Galbraith, Rachel L ^a   Duggan, David J ^f   Habermann, Nina ^g   Bailey, Lynn B ^h   Maneval, David R ⁱ   Caudill, Marie A ^j   Toriola, Adetunji T ^k   Green, Ralph ^d   Ulrich, Cornelia M ^a,g,l  

^a USA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h UNIVERSITY OF GEORGIA   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

^j Department of Obstetrics Gynecology   (United States)

^k Washington University in St Louis School of Medicine   (United States)

^l UNIVERSITY OF UTAH   (United States)

more..

Author keywords

biomarker; colorectal cancer; gene nutrient interaction; one carbon metabolism; postmenopausal women

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLDIALKYLPHOSPHATASE 1; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; THYMIDYLATE SYNTHASE; TRANSCOBALAMIN II; BIOLOGICAL MARKER; DNA BINDING PROTEIN; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; HISTONE LYSINE METHYLTRANSFERASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; MINOR HISTOCOMPATIBILITY ANTIGEN; MTHFD1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PRDM2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; VITAMIN B COMPLEX;

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE REDUCTASE GENE; AGED; ALANYL TRANSFER RNA SYNTHETASE GENE; ALCOHOL CONSUMPTION; ARTICLE; BETAINE HOMOCYSTEINE S METHYLTRANSFERASE 2 GENE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; CYSTATHIONINE B SYNTHASE GENE; DIHYDROFOLATE REDUCTASE GENE; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 3B GENE; FEMALE; FOLATE HYDROLASE 1 GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; METHIONINE ADENOSYLTRANSFERASE I ALPHA GENE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1 GENE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2 GENE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; NUTRITIONAL STATUS; PARAOXONASE 1 GENE; POSTMENOPAUSE; PR DOMAIN CONTAINING 2 WITH ZNF DOMAIN GENE; PRIORITY JOURNAL; PYRIDOXAL 5' PHOSPHATE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; THYMIDYLATE SYNTHASE GENE; TRANSCOBALAMIN II GENE; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LOGISTIC MODELS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RISK ASSESSMENT; TRANSCRIPTION FACTORS; VITAMIN B COMPLEX;

EID: 84943586393     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29465     Document Type: Article

References (32)

1. Ulrich CM, Robien K, McLeod HL,. Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer. 2003; 3: 912-920.
2. Bae S, Ulrich CM, Neuhouser ML, et al., Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study. Cancer Res. 2014; 74: 7442-7452.
3. Zschabitz S, Cheng TY, Neuhouser ML, et al., B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr. 2013; 97: 332-343.
4. Lee JE, Wei EK, Fuchs CS, et al., Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control. 2012; 23: 537-545.
5. Figueiredo JC, Levine AJ, Crott JW, Baurley J, Haile RW,. Folate-genetics and colorectal neoplasia: what we know and need to know next. Mol Nutr Food Res. 2013; 57: 607-627.
6. Levine AJ, Figueiredo JC, Lee W, et al., A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2010; 19: 1812-1821.
7. Koushik A, Kraft P, Fuchs CS, et al., Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2408-2417.
8. Chen J, Kyte C, Valcin M, et al., Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer. 2004; 110: 617-620.
9. Han SS, Sue LY, Berndt SI, et al., Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake. Cancer Epidemiol Biomarkers Prev. 2012; 21: 417-427.
10. Liu AY, Scherer D, Poole E, et al., Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res. 2013; 57: 721-734.
11. Miller JW, Ulrich CM,. Folic acid and cancer-where are we today? Lancet. 2013; 381: 974-976.
12. Mason JB, Choi SW,. Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol. 2005; 35: 235-241.
13. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M,. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003; 13: S107-S121.
14. Thorisson GA, Smith AV, Krishnan L, Stein LD,. The International HapMap Project Web site. Genome Res. 2005; 15: 1592-1593.
15. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA,. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004; 74: 106-120.
16. Marcuello E, Altes A, del Rio E, Cesar A, Menoyo A, Baiget M,. Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients. Int J Cancer. 2004; 112: 733-737.
17. Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O'Reilly DS,. Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 792: 333-343.
18. Gilfix BM, Blank DW, Rosenblatt DS,. Novel reductant for determination of total plasma homocysteine. Clin Chem. 1997; 43: 687-688.
19. Conneely KN, Boehnke M,. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet. 2007; 81: 1158-1168.
20. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I,. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001; 125: 279-284.
21. Curtin K, Samowitz WS, Ulrich CM, et al., Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer. 2011; 63: 357-366.
22. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489: 57-74.
23. Neuhouser ML, Cheng TY, Beresford SA, et al., Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative Observational Study. Int J Cancer. 2015. doi: 10.1002/ijc.29453. [Epub ahead of print]
24. Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R,. Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood. 2002; 100: 718-720.
25. Martinelli M, Scapoli L, Mattei G, et al., A candidate gene study of one-carbon metabolism pathway genes and colorectal cancer risk. Br J Nutr. 2013; 109: 984-989.
26. Miller JW, Beresford SA, Neuhouser ML, et al., Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr. 2013; 97: 827-834.
27. Van Der Logt EM, Janssen CH, Van Hooijdonk Z, et al., No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk. Anticancer Res. 2005; 25: 1465-1470.
28. Robertson KD, Uzvolgyi E, Liang G, et al., The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 1999; 27: 2291-2298.
29. Chadwick RB, Jiang GL, Bennington GA, et al., Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci U S A. 2000; 97: 2662-2667.
30. Jakubowski H,. Quality control in tRNA charging-editing of homocysteine. Acta Biochim Pol. 2011; 58: 149-163.
31. Pfeiffer CM, Johnson CL, Jain RB, et al., Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr. 2007; 86: 718-727.
32. Bae S, Ulrich CM, Bailey LB, et al., Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women's Health Initiative Observational Study cohort. Epigenetics. 2014; 9: 396-403.